BlackRock’s LENZ Therapeutics LENZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $42M | Buy |
1,432,461
+265,944
| +23% | +$7.79M | ﹤0.01% | 2520 |
|
|
2025
Q1 | $30M | Buy |
1,166,517
+10,892
| +0.9% | +$280K | ﹤0.01% | 2670 |
|
|
2024
Q4 | $33.4M | Buy |
1,155,625
+225,604
| +24% | +$6.51M | ﹤0.01% | 2678 |
|
|
2024
Q3 | $22.1M | Sell |
930,021
-30,023
| -3% | -$713K | ﹤0.01% | 2940 |
|
|
2024
Q2 | $16.6M | Buy |
960,044
+719,028
| +298% | +$12.4M | ﹤0.01% | 3042 |
|
|
2024
Q1 | $5.38M | Sell |
241,016
-10,415
| -4% | -$233K | ﹤0.01% | 3584 |
|
|
2023
Q4 | $4.61M | Sell |
251,431
-6,367
| -2% | -$117K | ﹤0.01% | 3650 |
|
|
2023
Q3 | $4.48M | Buy |
257,798
+13,539
| +6% | +$235K | ﹤0.01% | 3639 |
|
|
2023
Q2 | $4.45M | Buy |
244,259
+171,851
| +237% | +$3.13M | ﹤0.01% | 3689 |
|
|
2023
Q1 | $1.24M | Sell |
72,408
-1,962
| -3% | -$33.6K | ﹤0.01% | 4177 |
|
|
2022
Q4 | $1.73M | Buy |
74,370
+5,375
| +8% | +$125K | ﹤0.01% | 4113 |
|
|
2022
Q3 | $1.53M | Sell |
68,995
-720
| -1% | -$16K | ﹤0.01% | 4227 |
|
|
2022
Q2 | $1.34M | Sell |
69,715
-172,357
| -71% | -$3.32M | ﹤0.01% | 4326 |
|
|
2022
Q1 | $8.64M | Buy |
242,072
+68,891
| +40% | +$2.46M | ﹤0.01% | 3577 |
|
|
2021
Q4 | $15.1M | Buy |
173,181
+37,479
| +28% | +$3.26M | ﹤0.01% | 3375 |
|
|
2021
Q3 | $15.6M | Buy |
135,702
+120,905
| +817% | +$13.9M | ﹤0.01% | 3391 |
|
|
2021
Q2 | $3.18M | Buy |
+14,797
| New | +$3.18M | ﹤0.01% | 4006 |
|